THE BEST SIDE OF BLOCK PAIN RECEPTORS WITH PROLEVIATE

Getting recognized the palmitoylation motif of APLNR, we built a brief substrate sequence to competitively inhibit the palmitoylation of endogenous APLNR. This aggressive peptide, which targets the APLNR palmitoylation web site in combination with morphine, can inhibit the event of NCP, like pain incidence, microglial activation, and inflammatory a